STOP BLEEDING IN SECONDS
Our mission is to save lives. We provide a safe, effective, and reliable solution to stop bleeding.
There is an extreme need to stop bleeding quickly and effectively with a product that is safe, easily used, and able to be used at the point of care.
122 18th St, Brooklyn,
NY 11215, US.
Our Product | VETIGEL®
VETIGEL® is a single-use, prescription hemostatic gel for veterinary use only. VETIGEL® helps control bleeding in animals by achieving hemostasis in seconds. For additional information, refer to Instructions for Use.
Our plant-based technology has revolutionized the current standard of care by stopping traumatic and surgical bleeds in seconds without the need for manual pressure. Cresilon’s current and future product lines target veterinary, human trauma, and human surgical applications.
This biotech just raised $25M to develop plant-based gel that stops traumatic bleeding in seconds
InnovationRx: Healthcare’s 2023 Outlook, Covid Hospitalizations Are Rising And What To Know About RSV
Cresilon and Walter Reed Army Institute of Research Sign Cooperative R&D Agreement for Treatment of Traumatic Brain Injuries
“Cresilon is extremely proud and honored to be supporting the DoD and WRAIR in this critically important work,” said Joe Landolina, CEO of Cresilon. “This collaboration is a testament to the potential of our technology, and we are truly hopeful that it can make a difference in the treatment of TBI and in the precious lives of our soldiers.”
Hemostatic Gel Immediately Stops Multiple Types of Bleeds Without Need to Apply Pressure
Cresilon is using recycled algae, meaning algae or kelp that has washed up onto the shoreline. The vendors they work with are highly sustainable as they are not damaging kelp forests but salvaging material that has already washed up on beaches.
Interview: 17-year-old invents life-saving gel technology
When he was 17 years old, Joe Landolina created a revolutionary gel. Now, he is 29 years old and co-founder and CEO of Cresilon, his homegrown Brooklyn-based biotech company that recently submitted the gel for FDA 510(k) clearance for human use and raised $38.5 million in Series A3 financing last year. DDW’s Megan Thomas caught up with Landolina about his success story.
Stopping Bleeding with Algal-Based Polymers
“Catastrophic bleeding is a cause of death after a wide variety of wounds in humans and other animals. This week’s podcast speaks with Joe Landolina from Cresilon, describing natural polymers that immediately cease bleeding, along with their military, medical and veterinary applications.”
How This Plant-Based Gel Can Treat Wounds
“Welcome back to Cheddar Innovates brought to you by Curiosity Stream. Our next guest is bringing innovation to something we’ve all used before: the Band Aid- but he’s bringing it to the next level by creating a gel that instantly stops bleeding and seals wounds from small paper cuts to even major traumatic bleeds. Joining us now is Joe Landolina: CEO and Founder of Cresilon.”
Subscribe to our Newsletter
Stay in touch with us to get Cresilon’s latest news, investment opportunities, and product releases.